» Articles » PMID: 28356984

Interleukin-1β Activates Focal Adhesion Kinase and Src to Induce Matrix Metalloproteinase-9 Production and Invasion of MCF-7 Breast Cancer Cells

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 Mar 31
PMID 28356984
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-1β (IL-1b) is a pleiotropic cytokine that is important in tumor progression and invasion. Matrix metalloproteinase-9 (MMP-9), which is a secreted matrix-degrading enzyme, is one of the key regulators of tumor invasion and metastasis. The current report indicated that IL-1b promotes MMP-9 production and cell invasion in non-metastatic MCF-7 breast cancer cells. IL-1b activated focal adhesion kinase (FAK) and proto-oncogene tyrosine-protein kinase Src (Src). Moreover, inhibiting the Src/FAK pathway reduced the IL-1b-induced production of MMP-9 and cell invasion. To investigate the functional role of FAK in MMP-9 production cell lines expressing mutant FAK in FAK knock-out mouse fibroblasts were generated. In wild-type FAK-expressing cells, MMP-9 production was induced by IL-1b stimulation. By contrast, IL-1b-induced MMP-9 production was abrogated in FAK knock-out, FAK Y397F, FAK Y925F, and kinase dead mutant-expressing cells. Therefore the results of the current study indicate that FAK and Src kinases are activated by IL-1b and play a critical role in MMP-9 production and tumor cell invasion.

Citing Articles

ER O-glycosylation in synovial fibroblasts drives cartilage degradation.

Tran L, Chia J, Le Guezennec X, Tham K, Nguyen A, Sandrin V Nat Commun. 2025; 16(1):2535.

PMID: 40087276 DOI: 10.1038/s41467-025-57401-9.


IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer.

Oyende Y, Taus L, Fatatis A Cancers (Basel). 2025; 17(2).

PMID: 39858071 PMC: 11763358. DOI: 10.3390/cancers17020290.


Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression.

Tomecka P, Kunachowicz D, Gorczynska J, Gebuza M, Kuznicki J, Skinderowicz K Int J Mol Sci. 2024; 25(16).

PMID: 39201656 PMC: 11354349. DOI: 10.3390/ijms25168972.


Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis.

Arakil N, Akhund S, Elaasser B, Mohammad K Biomedicines. 2024; 12(5).

PMID: 38791037 PMC: 11117796. DOI: 10.3390/biomedicines12051075.


Studying Signaling Pathway Activation in TRAIL-Resistant Macrophage-Like Acute Myeloid Leukemia Cells.

Lomovskaya Y, Krasnov K, Kobyakova M, Kolotova A, Ermakov A, Senotov A Acta Naturae. 2024; 16(1):48-58.

PMID: 38698963 PMC: 11062100. DOI: 10.32607/actanaturae.27317.


References
1.
Amin A, Senga T, Oo M, Thant A, Hamaguchi M . Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk. Genes Cells. 2003; 8(6):515-23. DOI: 10.1046/j.1365-2443.2003.00652.x. View

2.
Irby R, Mao W, Coppola D, Kang J, Loubeau J, Trudeau W . Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet. 1999; 21(2):187-90. DOI: 10.1038/5971. View

3.
Voronov E, Carmi Y, Apte R . Role of IL-1-mediated inflammation in tumor angiogenesis. Adv Exp Med Biol. 2007; 601:265-70. DOI: 10.1007/978-0-387-72005-0_28. View

4.
Avizienyte E, Frame M . Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol. 2005; 17(5):542-7. DOI: 10.1016/j.ceb.2005.08.007. View

5.
Mitra S, Schlaepfer D . Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 2006; 18(5):516-23. DOI: 10.1016/j.ceb.2006.08.011. View